Otros idiomas Regeneron Pharmaceuticals, Inc.

Acciones

REGN

US75886F1075

Biotecnología e investigación médica

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 25/04/2025			Varia. Cinco días.	Varia. 1 de enero.
602,64 ^USD	+0,48 %		+7,01 %	-15,40 %

25/04	REGENERON PHARMACEUTICALS, INC. : Evercore ISI mantiene su recomendación de compra	ZM
24/04	REGENERON PHARMACEUTICALS, INC. : Baird permanece neutral	ZM

Otros idiomas

Sanofi: L'impact des taux de change pénalise l'action malgré de bons résultats	24/04
Sanofi-L'impact des taux de change pénalise l'action malgré de bons résultats	24/04
Sanofi-Le bénéfice opérationnel dépasse les les attentes au T1 grâce aux ventes de Dupixent et de nouveaux produits	24/04
FUJIFILM Holdings' Unit Secures $3 Billion, 10-Year Biologics Manufacturing Deal with Regeneron	23/04
Rebond des Bourses en Asie, espoir d'une désescalade entre Pékin et Washington	23/04
Japan's Nikkei ends at 3-week high on Wall Street rebound, tech boost	23/04
Japan's Nikkei tracks Wall Street rebound, jumps to three-week high	23/04
Sector Update: Health Care Stocks Rise in Afternoon Trading	22/04
How companies are responding to Trump's tariffs	22/04
How companies are responding to Trump's tariffs	22/04
Regeneron to invest over $3 billion to boost US manufacturing	22/04
3M, GE Aerospace, Verizon... Les valeurs à suivre aujourd'hui à Wall Street	22/04
Trump set his sights on Jerome Powell	22/04
Regeneron Partners With Fujifilm to Expand Manufacturing Capacity	22/04
Regeneron to invest over $3 billion to boost US manufacturing	22/04
Regeneron Pharmaceuticals : débourse plus de 3 milliards de dollars pour développer sa production aux Etats-Unis	22/04
Regeneron to Expand US Biologics Production Through $3 Billion Fujifilm Deal	22/04
Regeneron signs over $3 billion deal with contract drugmaker to boost US manufacturing	22/04
Fujifilm Diosynth Biotechnologies And Regeneron Sign 10-Year U.S. Manufacturing Agreement	22/04
Regeneron Announces New Investment In Manufacturing Of Its Biologic Medicines	22/04
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines	22/04
Regeneron Announces New Investment in Manufacturing of its Industry-Leading Biologic Medicines	22/04
Regeneron Announces New Investment in Manufacturing of its Biologic Medicines	22/04
USA-Les valeurs à suivre à Wall Street (actualisé)	22/04
Trump a (re)trouvé son bouc émissaire : Powell	22/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Acciones

Yancopoulos, CSO de Regeneron, habla de los fármacos para perder peso y de la cartera de productos en desarrollo

14 de enero 2025 a las 18:24